MYOVANT SCIENCES LTD's ticker is MYOV and the CUSIP is G637AM102. A total of 77 filers reported holding MYOVANT SCIENCES LTD in Q1 2020. The put-call ratio across all filers is 8.90 and the average weighting 1.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $6,307,993 | +860.1% | 233,976 | +539.0% | 0.01% | +600.0% |
| Q3 2022 | $657,000 | +83.0% | 36,616 | +26.7% | 0.00% | – |
| Q2 2022 | $359,000 | +2.6% | 28,907 | +9.9% | 0.00% | – |
| Q1 2022 | $350,000 | -24.1% | 26,314 | -11.3% | 0.00% | – |
| Q4 2021 | $461,000 | -22.9% | 29,655 | +11.3% | 0.00% | – |
| Q3 2021 | $598,000 | +2.0% | 26,642 | +2.3% | 0.00% | – |
| Q2 2021 | $586,000 | -11.7% | 26,055 | -19.3% | 0.00% | – |
| Q1 2021 | $664,000 | -12.6% | 32,290 | +17.4% | 0.00% | – |
| Q4 2020 | $760,000 | -2.2% | 27,513 | -50.2% | 0.00% | – |
| Q3 2020 | $777,000 | +98.2% | 55,299 | +191.1% | 0.00% | – |
| Q2 2020 | $392,000 | +174.1% | 18,999 | -0.1% | 0.00% | – |
| Q1 2020 | $143,000 | -43.0% | 19,010 | +17.3% | 0.00% | – |
| Q4 2019 | $251,000 | +221.8% | 16,202 | +8.9% | 0.00% | – |
| Q3 2019 | $78,000 | -15.2% | 14,884 | +46.8% | 0.00% | – |
| Q2 2019 | $92,000 | -40.6% | 10,140 | -23.3% | 0.00% | – |
| Q2 2017 | $155,000 | – | 13,222 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| NovaQuest Capital Management, L.L.C. | 3,474,645 | $26,234,000 | 74.74% |
| Opaleye Management Inc. | 656,000 | $4,953,000 | 1.31% |
| Ghost Tree Capital, LLC | 585,000 | $4,417,000 | 1.17% |
| Cormorant Asset Management, LP | 2,600,000 | $19,630,000 | 0.91% |
| Bellevue Group AG | 4,815,109 | $36,354,000 | 0.70% |
| Values First Advisors, Inc. | 32,818 | $247,777 | 0.30% |
| Amia Capital LLP | 41,970 | $317,000 | 0.28% |
| Ikarian Capital, LLC | 450,000 | $3,398,000 | 0.26% |
| Eventide Asset Management | 800,000 | $6,040,000 | 0.20% |
| Rock Springs Capital Management LP | 500,000 | $3,775,000 | 0.16% |